These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 14550856)

  • 21. New gradient high-performance liquid chromatography method for determination of donepezil hydrochloride assay and impurities content in oral pharmaceutical formulation.
    Kafkala S; Matthaiou S; Alexaki P; Abatzis M; Bartzeliotis A; Katsiabani M
    J Chromatogr A; 2008 May; 1189(1-2):392-7. PubMed ID: 18206895
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hyphenated HPLC-NMR and its applications in drug discovery.
    Peng SX
    Biomed Chromatogr; 2000 Oct; 14(6):430-41. PubMed ID: 11002280
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A stability-indicating HPLC method for the determination of glucosamine in pharmaceutical formulations.
    Shao Y; Alluri R; Mummert M; Koetter U; Lech S
    J Pharm Biomed Anal; 2004 May; 35(3):625-31. PubMed ID: 15137989
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluating the utility of ion mobility separation in combination with high-pressure liquid chromatography/mass spectrometry to facilitate detection of trace impurities in formulated drug products.
    Eckers C; Laures AM; Giles K; Major H; Pringle S
    Rapid Commun Mass Spectrom; 2007; 21(7):1255-63. PubMed ID: 17340559
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Determination of inorganic pharmaceutical counterions using hydrophilic interaction chromatography coupled with a Corona CAD detector.
    Huang Z; Richards MA; Zha Y; Francis R; Lozano R; Ruan J
    J Pharm Biomed Anal; 2009 Dec; 50(5):809-14. PubMed ID: 19616396
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Degradation of components in drug formulations: a comparison between HPLC and DSC methods.
    Ceschel GC; Badiello R; Ronchi C; Maffei P
    J Pharm Biomed Anal; 2003 Aug; 32(4-5):1067-72. PubMed ID: 12899995
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Control and analysis of hydrazine, hydrazides and hydrazones--genotoxic impurities in active pharmaceutical ingredients (APIs) and drug products.
    Elder DP; Snodin D; Teasdale A
    J Pharm Biomed Anal; 2011 Apr; 54(5):900-10. PubMed ID: 21145684
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Determination of certain drugs in binary mixtures formulations by second derivative ratio spectrophotometry and LC.
    El-Gindy A; Emara S; Hadad GM
    Farmaco; 2004 Sep; 59(9):703-12. PubMed ID: 15337436
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A HPLC validated assay of paclitaxel's related impurities in pharmaceutical forms containing Cremophor EL.
    Ciutaru D; Badea I; Lazara L; Nicolescu D; Tudose A
    J Pharm Biomed Anal; 2004 Feb; 34(3):493-9. PubMed ID: 15127804
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Simultaneous separation and determination of coenzyme Q(10) and its process related impurities by NARP-HPLC and atmospheric pressure chemical ionization-mass spectrometry (APCI-MS).
    Nageswara Rao R; Kumar Talluri MV; Shinde DD
    J Pharm Biomed Anal; 2008 Jun; 47(2):230-7. PubMed ID: 18243624
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Use of a quality-by-design approach to justify removal of the HPLC weight % assay from routine API stability testing protocols.
    Skrdla PJ; Wang T; Antonucci V; Dowling T; Ge Z; Ellison D; Curran J; Mohan G; Wyvratt J
    J Pharm Biomed Anal; 2009 Dec; 50(5):794-6. PubMed ID: 19596534
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Using of HPLC coupled with coulometric detector for the determination of biotin in pharmaceuticals.
    Zerzanová A; Zizkovský V; Kucera R; Klimes J; Jesenský I; Dohnal J; Barrón D
    J Pharm Biomed Anal; 2007 Dec; 45(5):730-5. PubMed ID: 17920225
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A critical review on the use of modern sophisticated hyphenated tools in the characterization of impurities and degradation products.
    Singh S; Handa T; Narayanam M; Sahu A; Junwal M; Shah RP
    J Pharm Biomed Anal; 2012 Oct; 69():148-73. PubMed ID: 22521633
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A 21st century HPLC workflow for process R&D.
    Karcher BD; Davies ML; Delaney EJ; Venit JJ
    Clin Lab Med; 2007 Mar; 27(1):93-111. PubMed ID: 17416304
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Simultaneous determination of benzydamine hydrochloride and five impurities in an oral collutory as a pharmaceutical formulation by high-performance liquid chromatography.
    Carlucci G; Iuliani P; Di Federico L
    J Chromatogr Sci; 2010 Nov; 48(10):854-9. PubMed ID: 21044418
    [TBL] [Abstract][Full Text] [Related]  

  • 36. High performance liquid chromatography determination of prulifloxacin and five related impurities in pharmaceutical formulations.
    Locatelli M; De Lutiis F; Carlucci G
    J Pharm Biomed Anal; 2013 May; 78-79():27-33. PubMed ID: 23434526
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmaceutical impurity identification: a case study using a multidisciplinary approach.
    Alsante KM; Boutros P; Couturier MA; Friedmann RC; Harwood JW; Horan GJ; Jensen AJ; Liu Q; Lohr LL; Morris R; Raggon JW; Reid GL; Santafianos DP; Sharp TR; Tucker JL; Wilcox GE
    J Pharm Sci; 2004 Sep; 93(9):2296-309. PubMed ID: 15295790
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Multiple heart-cutting two dimensional liquid chromatography mass spectrometry: Towards real time determination of related impurities of bio-pharmaceuticals in salt based separation methods.
    Petersson P; Haselmann K; Buckenmaier S
    J Chromatogr A; 2016 Oct; 1468():95-101. PubMed ID: 27667648
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Finding key impurities in different manufacturing routes of a drug substance using liquid chromatography/mass spectrometry followed by principal components analysis.
    Carrier D; Eckers C; Arnoult T; Thurston T; Major H
    Rapid Commun Mass Spectrom; 2007; 21(23):3946-8. PubMed ID: 17975854
    [No Abstract]   [Full Text] [Related]  

  • 40. Impurities in Drug Products and Active Pharmaceutical Ingredients.
    Kątny M; Frankowski M
    Crit Rev Anal Chem; 2017 May; 47(3):187-193. PubMed ID: 27686474
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.